PATENT CLAIM ANALYSIS

Application Number: 15775085
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "002400"]

Abstract:
The present invention relates to a novel peptide having both an antimicrobial effect and an immunocyte activity regulatory function, and a use thereof. The peptide of the present invention regulates immunocyte activity and also exhibits antimicrobial activity against various bacteria such as gram-negative bacteria and gram-positive bacteria, thereby being useful for treating various immune diseases such as atopic dermatitis and for treating diseases caused by the infection of pathogenic bacteria.

Claim (Index 2):
The peptide of  claim 1 , wherein an octanoyl group (CH 3 (CH 2 ) 6 CO\u2014) is added to an N-terminus.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.57447
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14323408', '14916079', '12278042', '12043920', '13779080']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.723235412320762
- 35 USC 102 Novelty (BERT): 0.521028312660803
- Combined Prediction Score: 0.7030147023547662
- Mean Citation Score: 195.145942
- Max Citation Score: 217.22838
- Similarity Product: 119.74988526962755

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test